Visualization and Analysis of Parkinson’s Disease Status and Therapy Patterns
Pages 466 - 479
Abstract
Parkinson’s disease is a neurodegenerative disease affecting people worldwide. Since the reasons for Parkinson’s disease are still unknown and currently there is no cure for the disease, the management of the disease is directed towards handling of the underlying symptoms with antiparkinson medications. In this paper, we present a method for visualization of the patients’ overall status and their antiparkinson medications therapy. The purpose of the proposed visualization method is multi-fold: understanding the clinicians’ decisions for therapy modifications, identification of the underlying guidelines for management of Parkinson’s disease, as well as identifying treatment differences between groups of patients. The resulting patterns of disease progression show that there are differences between male and female patients.
References
[1]
Blockeel, H., Raedt, L.D., Ramon, J.: Top-down induction of clustering trees. In: Proceedings of the 15th International Conference on Machine Learning, ICML 1998. pp. 55–63 (1998)
[2]
Dalrymple-Alford J. C., MacAskill M. R., Nakas C. T., Livingston L., Graham C., Crucian G. P., Melzer T. R., Kirwan J., Keenan R., Wells S., Porter R. J., Watts R., and Anderson T. J. The MoCA: Well-suited screen for cognitive impairment in Parkinson disease Neurology 2010 75 19 1717-1725
[3]
Ferreira J. J., Katzenschlager R., Bloem B. R., Bonuccelli U., Burn D., Deuschl G., Dietrichs E., Fabbrini G., Friedman A., Kanovsky P., Kostic V., Nieuwboer A., Odin P., Poewe W., Rascol O., Sampaio C., Schüpbach M., Tolosa E., Trenkwalder C., Schapira A., Berardelli A., and Oertel W. H. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease European Journal of Neurology 2012 20 1 5-15
[4]
Fox Susan H., Katzenschlager Regina, Lim Shen-Yang, Ravina Bernard, Seppi Klaus, Coelho Miguel, Poewe Werner, Rascol Olivier, Goetz Christopher G., and Sampaio Cristina The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease Movement Disorders 2011 26 S3 S2-S41
[5]
Goetz C, Luo S, Wang L, Tilley B, LaPelle N, and Stebbins G Handling missing values in the MDS-UPDRS Mov. Disord. 2015 30 12 1632-1638
[6]
Goetz, C., et al.: Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23(15), 2129–2170 (2008)
[7]
Guthrie, D., Allison, B., Liu, W., Guthrie, L., Wilks, Y.: A closer look at skip-gram modelling. In: Proceedings of the 5th International Conference on Language Resources and Evaluation, LREC 2006. pp. 1–4 (2006)
[8]
Kosara R and Miksch S Visualization methods for data analysis and planning in medical applications Int. J. Med. Inform. 2002 68 1 141-153
[9]
Marek, K., et al.: The Parkinson’s progression markers initiative (PPMI). Prog. Neurobiol. 95(4), 629–635 (2011)
[10]
National Collaborating Centre for Chronic Conditions: Parkinson’s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. Royal College of Physicians, London (2006)
[11]
Olanow W, Watts R, and Koller W An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines Neurology 2001 56 suppl 5 S1-S88
[12]
Plaisant, C., Milash, B., Rose, A., Widoff, S., Shneiderman, B.: Lifelines: visualizing personal histories. In: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, pp. 221–227. CHI 1996, ACM, New York, NY, USA (1996)
[13]
Seppi Klaus, Weintraub Daniel, Coelho Miguel, Perez-Lloret Santiago, Fox Susan H., Katzenschlager Regina, Hametner Eva-Maria, Poewe Werner, Rascol Olivier, Goetz Christopher G., and Sampaio Cristina The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease Movement Disorders 2011 26 S3 S42-S80
[14]
Struyf, J., Ženko, B., Blockeel, H., Vens, C., Džeroski, S.: CLUS: User’s Manual (2010)
[15]
Tsanas, A.: Accurate telemonitoring of Parkinsons disease symptom severity using nonlinear speech signal processing and statistical machine learning. Ph.D. thesis, Oxford University, UK (2012)
[16]
Tsanas A, Little M, McSharry P, and Ramig L Accurate telemonitoring of Parkinson’s disease progression by noninvasive speech tests IEEE Trans. Biomed. Eng. 2010 57 4 884-893
[17]
Tsanas A, Little MA, McSharry PE, and Ramig LO Accurate telemonitoring of Parkinson’s disease progression by noninvasive speech tests IEEE Trans. Biomed. Eng. 2010 57 4 884-893
[18]
Tsanas, A., Little, M.A., McSharry, P.E., Ramig, L.O.: Enhanced classical Dysphonia measures and sparse regression for telemonitoring of Parkinson’s disease progression. In: Proceedings of the IEEE International Conference on Acoustics Speech and Signal Processing, ICASSP 2010, pp. 594–597. IEEE (2010)
[19]
Tsanas A, Little MA, McSharry PE, Spielman J, and Ramig LO Novel speech signal processing algorithms for high-accuracy classification of Parkinson’s disease IEEE Trans. Biomed. Eng. 2012 59 5 1264-1271
[20]
Tufte ER The Visual Display of Quantitative Information 2001 Cheshire, CT, USA Graphics Press
[21]
Valmarska, A., Miljkovic, D., Konitsiotis, S., Gatsios, D., Lavrač, N., Robnik-Šikonja, M.: Symptoms and medications change patterns for Parkinson’s disease patients stratification. Artif. Intell. Med. (2018).
[22]
Valmarska A, Miljkovic D, Lavrač N, and Robnik-Šikonja M Analysis of medications change in Parkinson’s disease progression data J. Intell. Inf. Syst. 2018 51 2 301-337
[23]
Valmarska, A., Miljkovic, D., Robnik-Šikonja, M., Lavrač, N.: Multi-view approach to Parkinson’s disease quality of life data analysis. In: Proceedings of the International Workshop on New Frontiers in Mining Complex Patterns, pp. 163–178. Springer (2016)
[24]
Visser M, Marinus J, Stiggelbout AM, and Van Hilten JJ Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT Mov. Disord. 2004 19 11 1306-1312
[25]
Washburn RA, Smith KW, Jette AM, and Janney CA The physical activity scale for the elderly (PASE): development and evaluation J. Clin. Epidemiol. 1993 46 2 153-162
Recommendations
Stratification of Parkinson’s Disease Patients via Multi-view Clustering
Artificial Intelligence in MedicineAbstractParkinson’s disease is a neurodegenerative disease characterised by heterogeneity of the sets of symptoms patients experience and the trajectories of disease progression. The PPMI study includes patients’ symptoms explaining different aspects of ...
Mobile-based Monitoring of Parkinson's Disease
MUM '18: Proceedings of the 17th International Conference on Mobile and Ubiquitous MultimediaParkinson's disease (PD) is the second most common neurodegenerative disorder, impacting an estimated seven to ten million people worldwide. It is commonly accepted that improving medication adherence alleviates symptoms and maintains motor ...
Analysis of medications change in Parkinson's disease progression data
Parkinson's disease is a neurodegenerative disorder that affects people worldwide. Careful management of patient's condition is crucial to ensure the patient's independence and quality of life. This is achieved by personalized treatment based on ...
Comments
Information & Contributors
Information
Published In
Oct 2018
486 pages
ISBN:978-3-030-01770-5
DOI:10.1007/978-3-030-01771-2
© Springer Nature Switzerland AG 2018.
Publisher
Springer-Verlag
Berlin, Heidelberg
Publication History
Published: 29 October 2018
Author Tags
Qualifiers
- Article
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 0Total Downloads
- Downloads (Last 12 months)0
- Downloads (Last 6 weeks)0
Reflects downloads up to 11 Aug 2024
Other Metrics
Citations
View Options
View options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign in